Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 47 Melanoma 23 Neoplasm Metastasis 19 Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 13 Skin Neoplasms 12 Recurrence 10 Head and Neck Neoplasms 10 Carcinoma, Renal Cell 9 Prostatic Neoplasms 8 Ovarian Neoplasms 8 Colorectal Neoplasms 8 Carcinoma, Squamous Cell 8 Breast Neoplasms 8 Urinary Bladder Neoplasms 7 Carcinoma, Merkel Cell 7 Triple Negative Breast Neoplasms 6 Colonic Neoplasms 6 Carcinoma, Basal Cell 6 Carcinoma 6 Adenocarcinoma 6 Uterine Cervical Neoplasms 5 Sarcoma 5 Pancreatic Neoplasms 5 Glioblastoma 5 Stomach Neoplasms 4 Multiple Myeloma 4 Mouth Neoplasms 4 Fallopian Tube Neoplasms 4

Interventions

Radiotherapy 9 Cisplatin 9 pembrolizumab 6 Methods 6 fludarabine 4 Papillomavirus Vaccines 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Early Intervention, Educational 4 Cyclophosphamide 4 durvalumab 3 aldesleukin 3 Vaccines, Synthetic 3 Vaccines 3 Radiosurgery 3 Radiation 3 Platinum 3 Palliative Care 3 Paclitaxel 3 Nivolumab 3 Gemcitabine 3 Carboplatin 3 Brachytherapy 3 Bleomycin 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 lenvatinib 2 entinostat 2 aflibercept 2 Trastuzumab 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vulvar Neoplasms × cemiplimab × Clear all

NCT07101848 2025-08-03

BRAVA VULVAR

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡